JONBUR Research · Update note
You're reading an earlier report from Oct 21, 2026. See the latest report
KolmarBNH · 200130 · Biotech & Pharma
KolmarBNH: Model Fair Value Estimate Halves to ₩12,979 per Share
Why this report
Written after:
- Model fair value changeModel estimate of fair value moved -50% (₩25,939 → ₩12,979 per share)Oct 22, 2026
Our model estimate of KolmarBNH's fair value fell 50.0% to ₩12,979 per share in the base case, from ₩25,939 in the previous report. The change comes from the model inputs, not from a new company filing, and it narrows but does not close the gap to the ₩7,850 share price.
Written Oct 21, 2026 · Data as of Oct 20, 2026 · 0 views
This is not financial advice. The report does not recommend buying or selling anything.
What happened
On 2026-10-22 the model estimate of fair value was cut from ₩25,939 to ₩12,979 per share in the base case, a fall of 50.0%. No company filings or news were attached to this event, and no smaller recent events were flagged as background.
The model is still a 5-year discounted cash flow based on trailing figures to H1 2026. The discount rate shown is now 7.0%, versus 7.5% in the previous report. A lower rate would normally raise a value, so the halving must come from other model inputs that the data does not detail. The reason for the cut therefore cannot be determined here.
The underlying trailing figures shown are the same as before: revenue ₩538.2B, operating income ₩32.9B (6.1% margin), net income -₩1.6B and free cash flow ₩29.2B. Borrowings are ₩108.1B against cash of ₩76.1B. The previous report described the company as debt-free, which does not match the borrowings figure in the current data.
Every earlier JONBUR Research report and update note on KolmarBNH, with Pro.
Unlock with ProModel estimate of fair value
- Bear
- ₩5,482
- -25%
- Base
- ₩12,979
- +78%
- Bull
- ₩26,506
- +263%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Base case of the 5-year discounted cash flow model on the stock's Valuation tab (statements TTM to H1 2026; discount rate 7%). Bear and Bull move the main assumptions by fixed steps. See and change the assumptions
Filings and data used
- 5%+ holding reportSep 30, 2026
- Amended: Acquisition of shares in another companySep 2, 2026
- Disclosure on Large Business Group Status [Quarterly Disclosure (For Individual Company)]Aug 28, 2026
- [Attached Correction] Sustainability Report and Related Matters (Voluntary Disclosure)Aug 19, 2026
- Amended: Cash dividend decisionAug 14, 2026
- [Amended Filing] Closure of Shareholder Register for Cash and Stock Dividends (Record Date) DecisionAug 14, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- Matters Concerning Payment Amounts by Payment Method and Payment Period, and Dispute Mediation BodiesAug 14, 2026
- Acquisition of shares in another companyAug 12, 2026
- Share cancellation decisionAug 12, 2026
- Cash dividend decisionAug 12, 2026
- Shareholder Register Closure for Cash/Stock Dividend (Record Date) DecisionAug 12, 2026
- Daily prices up to 2026-10-20
- Financial statements, trailing 12 months as of H1 2026
- Our fair value model, statements as of TTM to H1 2026
Report history
- Oct 28, 2026Update noteM&A / restructuringKolmarBNH to Absorb Wholly Owned Subsidiary HNG in No-Share-Issue Merger
- Oct 21, 2026Update noteModel fair value changeKolmarBNH: Model Fair Value Estimate Halves to ₩12,979 per Share
- Oct 18, 2026InitiationStart of coverage (reader request)KolmarBNH: Share Price Down 46.6% Over a Year as Profits Slip Into a Net Loss
Source: KRX statistical information